“Collateral Damage” From Pharma Regs Poses Threat To Homeopathics
This article was originally published in The Tan Sheet
Executive Summary
The biggest threat to the homeopathic drug industry is “collateral damage” from regulation of pharmaceuticals, an industry leader says.
You may also be interested in...
FDA Wants Authority To Enforce Track-And-Trace System For Drugs
Congress should empower FDA to enforce the track-and-trace standard for drugs that the agency already is tasked with developing, Deputy Commissioner for Global Regulatory Operations and Policy Deborah Autor told the Senate Health, Education, Labor and Pensions Committee Sept. 14.
FDA Regulation Of Homeopathics Does Not Pre-empt Damages Claims – Court
A federal judge rejected an argument that FDA’s regulation of homeopathic drugs pre-empts a state consumer protection law.
Coalition Pushes Congress On OTC Purchases With Health Savings Accounts
The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.